» Download Public Reports
54 reports
- Industry report
- May 2013
- 7 pages
- by Intergovernmental Agency
... Materials From the who- gisrs, such as influenza vaccine, diagnostic and pharmaceutical manufactus, as well as biotechnology firms, research institutions and academic institutions. The pip framework ...
March 2013
... Are seen first and foremost as businesses, in other words, as players seeking to make a profit: 90% (-1) Of the french and 96% of doctors believe that the aim of drug companies is to make a profit ...
March 2013
... Regulations regarding the import of investigational or pre-launch medications for cu 9 compassionate use programmes National programmes differ due to differences in: National medical practices ...
December 2012
... Of generic 21 vancomycin (van) products approved for use in humans, based on experiments in a 22 neutropenic mouse thigh infection model. However, other animal models may be more 23 appropriate to decipher ...
October 2012
... Data on the intestinal microflora as well as the results of the bioassays for antibiotic concentrations in faecal samples, telavancin has a favourable ecological profile. Antimicrobial resistance ...
September 2012
... Needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health ...
September 2012
... Usually outweigh potential risks when the likelihood of disease exposure is high, when infection would pose a risk to the mother or fetus, and when the vaccine is unlikely to cause harm. *Cdc general ...
July 2012
... And development, future clinical data and analysis, including post marketing, s by regulatory authorities, such as the fda or the ema, regarding whether and when to approve any drug, device or biological ...